Lufax (LU) Stock Forecast, Price Target & Predictions
LU Stock Forecast
Lufax stock forecast is as follows: an average price target of $3.80 (represents a 70.40% upside from LU’s last price of $2.23) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.
LU Price Target
The average price target for Lufax (LU) is $3.80 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $5.20 to $2.40. This represents a potential 70.40% upside from LU's last price of $2.23.
LU Analyst Ratings
According to 12 Wall Street analysts, Lufax's rating consensus is 'Buy'. The analyst rating breakdown for LU stock is 0 'Strong Buy' (0.00%), 7 'Buy' (58.33%), 2 'Hold' (16.67%), 3 'Sell' (25.00%), and 0 'Strong Sell' (0.00%).
Lufax Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 07, 2024 | Richard Xu | Morgan Stanley | $2.40 | $2.42 | -0.83% | 7.62% |
| Apr 10, 2024 | Richard Xu | Morgan Stanley | $4.50 | $4.44 | 1.35% | 101.79% |
| Mar 22, 2024 | Carson Lo | HSBC | $5.20 | $4.48 | 16.07% | 133.18% |
| Nov 25, 2022 | Carson Lo | HSBC | $2.00 | $1.75 | 14.29% | -10.31% |
The latest Lufax stock forecast, released on Jun 07, 2024 by Richard Xu from Morgan Stanley, set a price target of $2.40, which represents a -0.83% decrease from the stock price at the time of the forecast ($2.42), and a 7.62% increase from LU last price ($2.23).
Lufax Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $4.03 |
| Last Closing Price | $2.23 | $2.23 | $2.23 |
| Upside/Downside | -100.00% | -100.00% | 80.72% |
In the current month, the average price target of Lufax stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Lufax's last price of $2.23. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 07, 2024 | Morgan Stanley | Reduce | Reduce | Hold |
| Apr 24, 2024 | CLSA | Buy | Outperform | Upgrade |
| Apr 23, 2024 | Citigroup | Neutral | Neutral | Hold |
| Aug 23, 2023 | Goldman Sachs | Neutral | Neutral | Hold |
| May 16, 2023 | Macquarie | - | Outperform | Upgrade |
| May 16, 2023 | Deutsche Bank | - | Buy | Upgrade |
| May 16, 2023 | New Street | - | Buy | Upgrade |
| May 16, 2023 | Morgan Stanley | - | Underweight | Downgrade |
| May 16, 2023 | Keefe, Bruyette & Woods | - | Outperform | Upgrade |
| May 16, 2023 | Argus Research | - | Buy | Upgrade |
Lufax's last stock rating was published by Morgan Stanley on Jun 07, 2024. The company gave LU a "Reduce" rating, the same as its previous rate.
Lufax Financial Forecast
Lufax Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | $8.33B | $10.16B | $11.29B | $13.48B | $15.52B | $13.67B | $14.10B | $13.07B | $13.48B | $12.64B | $9.81B |
| Avg Forecast | $19.74B | $10.36B | $11.40B | $12.32B | $7.73B | $6.17B | $6.43B | $6.81B | $7.57B | $8.80B | $10.12B | $12.03B | $12.01B | $14.49B | $15.99B | $2.58B | $2.33B | $2.53B | $2.31B | $2.22B | $1.93B | $1.93B |
| High Forecast | $19.74B | $10.36B | $11.40B | $12.32B | $7.73B | $6.17B | $6.43B | $6.81B | $7.57B | $8.80B | $10.12B | $12.03B | $12.01B | $14.49B | $15.99B | $2.62B | $2.37B | $2.56B | $2.34B | $2.26B | $1.96B | $1.96B |
| Low Forecast | $19.74B | $10.36B | $11.40B | $12.32B | $7.73B | $6.17B | $6.43B | $6.81B | $7.57B | $8.80B | $10.12B | $12.03B | $12.01B | $14.49B | $15.99B | $2.54B | $2.30B | $2.49B | $2.27B | $2.19B | $1.90B | $1.90B |
| # Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.85% | 0.78% | 0.84% | 6.02% | 5.86% | 5.58% | 5.66% | 6.06% | 6.54% | 5.08% |
Lufax's average Quarter revenue forecast for Jun 23 based on 1 analysts is $10.12B, with a low forecast of $10.12B, and a high forecast of $10.12B. LU's average Quarter revenue forecast represents a 21.45% increase compared to the company's last Quarter revenue of $8.33B (Mar 23).
Lufax EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | $1.24B | $-111.54M | $2.39B | $4.55B | $7.35B | $14.03B | $6.17B | $6.67B | $7.03B | $7.87B | $5.30B |
| Avg Forecast | $6.85B | $3.60B | $3.96B | $4.28B | $2.68B | $2.14B | $2.23B | $2.37B | $2.63B | $3.06B | $3.51B | $4.18B | $4.17B | $5.03B | $5.55B | $1.22B | $1.11B | $1.20B | $1.10B | $1.06B | $917.96M | $916.79M |
| High Forecast | $6.85B | $3.60B | $3.96B | $4.28B | $2.68B | $2.14B | $2.23B | $2.37B | $2.63B | $3.06B | $3.51B | $4.18B | $4.17B | $5.03B | $5.55B | $1.24B | $1.12B | $1.22B | $1.11B | $1.07B | $931.45M | $930.26M |
| Low Forecast | $6.85B | $3.60B | $3.96B | $4.28B | $2.68B | $2.14B | $2.23B | $2.37B | $2.63B | $3.06B | $3.51B | $4.18B | $4.17B | $5.03B | $5.55B | $1.21B | $1.09B | $1.18B | $1.08B | $1.04B | $904.47M | $903.31M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.30% | -0.03% | 0.47% | 0.82% | 6.01% | 12.67% | 5.14% | 6.09% | 6.66% | 8.57% | 5.78% |
1 analysts predict LU's average Quarter EBITDA for Jun 23 to be $3.51B, with a high of $3.51B and a low of $3.51B. This is 182.74% upper than Lufax's previous annual EBITDA (Mar 23) of $1.24B.
Lufax Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | $671.98M | $-805.93M | $1.33B | $2.91B | $5.28B | $2.90B | $4.13B | $4.77B | $5.00B | $2.89B | $2.18B |
| Avg Forecast | $5.38B | $196.28M | $777.58M | $1.31B | $693.17M | $-23.40M | $143.23M | $32.49B | $-78.28M | $612.89M | $881.26M | $33.03B | $-756.40M | $23.98B | $3.61B | $4.37B | $11.25B | $3.59B | $3.78B | $4.44B | $2.35B | $12.17B |
| High Forecast | $5.38B | $196.28M | $777.58M | $1.31B | $693.17M | $-23.40M | $143.23M | $38.98B | $-78.28M | $612.89M | $881.26M | $39.64B | $-756.40M | $28.77B | $3.61B | $5.24B | $11.47B | $4.31B | $4.53B | $5.33B | $2.81B | $12.40B |
| Low Forecast | $5.38B | $196.28M | $777.58M | $1.31B | $693.17M | $-23.40M | $143.23M | $25.99B | $-78.28M | $612.89M | $881.26M | $26.43B | $-756.40M | $19.18B | $3.61B | $3.50B | $11.04B | $2.87B | $3.02B | $3.55B | $1.88B | $11.93B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.02% | 1.07% | 0.06% | 0.81% | 1.21% | 0.26% | 1.15% | 1.26% | 1.13% | 1.23% | 0.18% |
Lufax's average Quarter net income forecast for Jun 23 is $881.26M, with a range of $881.26M to $881.26M. LU's average Quarter net income forecast represents a 31.14% increase compared to the company's last Quarter net income of $671.98M (Mar 23).
Lufax SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | $3.79B | $4.46B | $5.15B | $4.74B | $5.66B | $6.40B | $6.07B | $5.63B | $5.53B | $6.33B | $5.43B |
| Avg Forecast | $8.85B | $4.64B | $5.11B | $5.52B | $3.47B | $2.77B | $2.88B | $3.06B | $3.40B | $3.95B | $4.54B | $5.39B | $5.38B | $6.50B | $7.17B | $1.16B | $1.05B | $1.13B | $1.04B | $996.90M | $866.93M | $865.82M |
| High Forecast | $8.85B | $4.64B | $5.11B | $5.52B | $3.47B | $2.77B | $2.88B | $3.06B | $3.40B | $3.95B | $4.54B | $5.39B | $5.38B | $6.50B | $7.17B | $1.17B | $1.06B | $1.15B | $1.05B | $1.01B | $879.67M | $878.54M |
| Low Forecast | $8.85B | $4.64B | $5.11B | $5.52B | $3.47B | $2.77B | $2.88B | $3.06B | $3.40B | $3.95B | $4.54B | $5.39B | $5.38B | $6.50B | $7.17B | $1.14B | $1.03B | $1.12B | $1.02B | $982.24M | $854.18M | $853.09M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.70% | 0.83% | 0.79% | 0.66% | 4.89% | 6.12% | 5.36% | 5.44% | 5.55% | 7.30% | 6.27% |
Lufax's average Quarter SG&A projection for Jun 23 is $4.54B, based on 1 Wall Street analysts, with a range of $4.54B to $4.54B. The forecast indicates a 19.86% rise compared to LU last annual SG&A of $3.79B (Mar 23).
Lufax EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | $0.30 | $-0.35 | $0.58 | $1.27 | $2.31 | $1.25 | $1.76 | $2.00 | $2.09 | $1.25 | $0.90 |
| Avg Forecast | $9.38 | $0.34 | $1.36 | $2.29 | $1.21 | $-0.04 | $0.25 | $0.23 | $-0.14 | $1.07 | $1.54 | $0.57 | $-1.32 | $4.86 | $6.31 | $7.81 | $4.80 | $6.39 | $6.07 | $7.10 | $3.98 | $5.19 |
| High Forecast | $9.38 | $0.34 | $1.36 | $2.29 | $1.21 | $-0.04 | $0.25 | $0.23 | $-0.14 | $1.07 | $1.54 | $0.57 | $-1.32 | $4.86 | $6.31 | $7.96 | $4.89 | $6.51 | $6.19 | $7.23 | $4.05 | $5.29 |
| Low Forecast | $9.38 | $0.34 | $1.36 | $2.29 | $1.21 | $-0.04 | $0.25 | $0.23 | $-0.14 | $1.07 | $1.54 | $0.57 | $-1.32 | $4.86 | $6.31 | $7.66 | $4.71 | $6.27 | $5.96 | $6.96 | $3.90 | $5.09 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.53% | 0.27% | 0.12% | 0.20% | 0.30% | 0.26% | 0.28% | 0.33% | 0.29% | 0.31% | 0.17% |
According to 1 Wall Street analysts, Lufax's projected average Quarter EPS for Jun 23 is $1.54, with a low estimate of $1.54 and a high estimate of $1.54. This represents a 412.51% increase compared to LU previous annual EPS of $0.30 (Mar 23).
Lufax Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| GDOT | Green Dot | $11.52 | $25.00 | 117.01% | Hold |
| LU | Lufax | $2.23 | $3.80 | 70.40% | Buy |
| ATLC | Atlanticus | $31.40 | $43.50 | 38.54% | Buy |
| QFIN | 360 DigiTech | $25.08 | $28.15 | 12.24% | Buy |
| FINV | FinVolution Group | $5.30 | $5.94 | 12.08% | Buy |
| SYF | Synchrony Financial | $47.13 | $51.94 | 10.21% | Buy |
| NAVI | Navient | $15.77 | $16.00 | 1.46% | Sell |
| ENVA | Enova | $79.32 | $60.75 | -23.41% | Buy |
LU Forecast FAQ
Is Lufax a good buy?
Yes, according to 12 Wall Street analysts, Lufax (LU) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 58.33% of LU's total ratings.
What is LU's price target?
Lufax (LU) average price target is $3.8 with a range of $2.4 to $5.2, implying a 70.40% from its last price of $2.23. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Lufax stock go up soon?
According to Wall Street analysts' prediction for LU stock, the company can go up by 70.40% (from the last price of $2.23 to the average price target of $3.8), up by 133.18% based on the highest stock price target, and up by 7.62% based on the lowest stock price target.
Can Lufax stock reach $3?
LU's average twelve months analyst stock price target of $3.8 supports the claim that Lufax can reach $3 in the near future.
What are Lufax's analysts' financial forecasts?
Lufax's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $27.14B (high $27.14B, low $27.14B), average EBITDA is $9.42B (high $9.42B, low $9.42B), average net income is $33.3B (high $39.8B, low $26.8B), average SG&A $12.17B (high $12.17B, low $12.17B), and average EPS is $1.65 (high $1.65, low $1.65). LU's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $53.82B (high $53.82B, low $53.82B), average EBITDA is $18.68B (high $18.68B, low $18.68B), average net income is $7.66B (high $7.66B, low $7.66B), average SG&A $24.14B (high $24.14B, low $24.14B), and average EPS is $13.37 (high $13.37, low $13.37).
Did the LU's actual financial results beat the analysts' financial forecasts?
Based on Lufax's last annual report (Dec 2022), the company's revenue was $50.45B, beating the average analysts forecast of $45.06B by 11.95%. Apple's EBITDA was $14.18B, missing the average prediction of $15.97B by -11.25%. The company's net income was $8.7B, missing the average estimation of $31.2B by -72.12%. Apple's SG&A was $18.59B, missing the average forecast of $20.21B by -8.02%. Lastly, the company's EPS was $3.8, missing the average prediction of $17.66 by -78.49%. In terms of the last quarterly report (Mar 2023), Lufax's revenue was $8.33B, missing the average analysts' forecast of $12.03B by -30.72%. The company's EBITDA was $1.24B, missing the average prediction of $4.18B by -70.24%. Lufax's net income was $671.98M, missing the average estimation of $33.03B by -97.97%. The company's SG&A was $3.79B, missing the average forecast of $5.39B by -29.80%. Lastly, the company's EPS was $0.3, missing the average prediction of $0.569 by -47.28%